Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumors

Seminars in Nuclear Medicine

Volumn 15, Issue 2, 1985, Pages 132-153

  McEwan, Alexander J ^a,b   Shapiro, Brahm ^a,b   Sisson, James C ^a,b   Beierwaltes, William H ^a,b   Ackery, Duncan M ^a,b  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; IODOBENZENE; RADIOACTIVE IODINE;

ADRENAL TUMOR; ADULT; AGED; CASE REPORT; CHILD; FEMALE; HUMAN; MALE; PHEOCHROMOCYTOMA; REVIEW; SCINTISCANNING;

3-IODOBENZYLGUANIDINE; ADRENAL GLAND NEOPLASMS; ADULT; AGED; CASE REPORT; CHILD; FEMALE; HUMAN; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MIDDLE AGE; PHEOCHROMOCYTOMA; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0022052846     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-2998(85)80022-2     Document Type: Article

References (94)

1. Current concepts of pheochromocytoma
2. Mucusal ganglioneuromatosis, medullary thyroid carcinoma and pheochromocytoma: Multiple endocrine neoplasia, type 2B
3. Familial occurrence of parathyroid adenomas, pheochromocytoma and medullary carcinoma of the thyroid with amyloid stroma (Sipple's syndrome)
4. Neoplastic complications of neurofibromatosis
5. Von Recklinghausen's disease: A clinico-pathological study
6. Malignant carcinoid and pheochromocytoma in Von Hippel-Lindau disease. A case report
7. Hippel-Lindau syndrome
8. Adrenal medullary hyperplasia: A morphometric analysis in patients with familial medullary carcinoma
9. Hypertension secondary to pheochromocytoma
10. Malignant pheochromocytoma Scand
11. One hundred cases of pheochromocytoma (107) tumors at the Columbia-Presbyterian Medical Center, 1926–1976. A clinicopathological analysis
12. Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system
13. The evaluation and management of pheochromocytomas
14. Anatomy and biochemistry of the sympathetic nervous system
15. Neurohumoral transmission and the autonomic nervous system
16. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series
17. Pheochromocytoma: Current diagnosis and management
18. Pheochromocytoma in the adult and in the child
19. Malignant pheochromocytoma in childhood
20. Pheochromocytoma in children—An update
21. Simultaneous single isotope radibenzymatic assay of plasma norepinephrine, epinephrine and dopamine
22. The estimation of catecholamines in urine
23. Circulating and urinary catecholamines in pheochromocytoma: Diagnostic and pathophysiologic implications
24. Clonidine-suppression test: A useful aid in the diagnosis of pheochromocytoma
25. Techniques, usefulness and hazards of arteriography of pheochromocytoma: Review of 99 cases
26. Angiography of extra-adrenal pheochromocytoma
27. Sonography of the adrenal glands, normal glands and small masses
28. Sonography of adrenal pheochromocytomas
29. Selective venous sampling in the diagnosis and localization of pheochromocytoma
30. Localization of pheochromocytoma by caval catheterization
31. Localization of pheochromocytoma by computed tomography
32. Localization of functional adrenal tumors by computed tomography and venous sampling
33. Computed tomography in adrenal disease
34. Scintigraphic localization of pheochromocytoma
35. Phaeochromocytoma: Current status and changing trends
36. Diagnosis of adrenal disease by visualization of human adrenal glands with 19-iodocholesterol
37. The concentration of radioactivity from labeled epinephrine and its precursors in the dog adrenal medulla
38. Labeled dopamine concentration in human adrenal medulla and in neuroblastoma
39. 11C-l-dopamine hydrochloride: X
40. Labeled dopamine concentration in pheochromocytomas
41. Radiopharmaceuticals. 16. Halogenated dopamine analogs. Synthesis and radiolabeling of 6-iododopamine and tissue distribution studies in animals
42. Concentration of dopamine analogs in the adrenal medulla
43. A radioiodinated bretylium analog as a potential agent for scanning the adrenal medulla
44. Imaging the adrenal medulla with an I-131-labeled antiadrenergic agent
45. Adrenal imaging with I-131-p-iodobenzylguanidine
46. 131I]iodobenzylguanidine
47. Myocardial imaging with a radioiodinated norepinephrine storage analog
48. 123I-meta-iodobenzylguanidine
49. 131I meta-iodobenzylguanidine. Concise communication
50. Human absorbed dose calculations for iodine 131 and iodine 123 labelled MIBG A potential myocardial and adrenal medulla imaging agent
51. Radiopharmaceutical treatment of malignant pheochromocytoma
52. Mechanism of uptake of norepinephrine and meta-iodobenzylguanidine into cultured human pheochromocytoma cells
53. Mechanisms of uptake of NE and MIBG into cultured bovine adrenomedullary cells. Evidence for uptake I
54. 131I meta-iodobenzylguanidine in humans
55. 131I-MIBG
56. Scintigraphic localization of phaeochromocytoma
57. 131I-MIBG
58. MIBG in the evaluation of suspected phaeochromocytoma: Mayo Clinic experience
59. MIBG scintigraphy: A one-year experience
60. 131I mIBG
61. 131I mIBG
62. Malignant pheochromocytoma: Clinical, biochemical and scintigraphic characterization
63. 123I-meta-iodobenzylguanidine: Synthesis and imaging the adrenal medullae and pheochromocytoma
64. The normal and abnormal distribution of the adrenomedullary imaging agent m[I-131]iodobenzylguanidine (131-I-MIBG) in man: Evaluation by scintigraphy
65. Portrayal of pheochromocytoma and normal human adrenal medulla by 123-I-meta-iodobenzylguanidine (123-I-MIBG)
66. False positive diagnosis of bilateral pheochromocytoma by iodine-131-labelled meta-iodobenzylguanidine
67. Salivary gland accumulation of meta [131-I-]iodobenzylguanidine
68. Heart imaging in the diagnosis of pheochromocytoma and assessment of catecholamine uptake
69. 131I-MIBG and circulating catecholamines in suspected pheochromocytoma
70. Rigorous biochemical criteria for the diagnosis of pheochromocytoma
71. Sensitivity and specificity of mIBG scintigraphy for the detection of phecochromocytoma
72. Intrathoracic pheochromocytoma a diagnostic dilemma solved by 131-I-metaiodobenzylguanidine scintigraphy
73. The location of middle mediastinal pheochromocytomas
74. Familial occurrence of parathyroid adenomas, phaeochromocytoma and medullary carcinoma of the thyroid with amyloid stroma (Sipples syndrome)
75. Multiple endocrine neoplasia type 2
76. The spectrum of pheochromocytoma in hypertensive patients with neurofibromatosis
77. 131I-meta-iodobenzylguanidine
78. Pheochromocytoma in children. Report of 9 cases and a review of the first 100 published cases with follow-up studies
79. Dopamine excretion in benign pheochromocytoma
80. Significance of urinary 3-O methyl dopamine in the metabolism of adrenergic tumors
81. Treatment of malignant pheochromocytoma
82. 131I-MIBG in the treatment of malignant pheochromocytomas
83. 131I-MIBG treatment of malignant pheochromocytoma
84. Radiopharmaceutical treatment of malignant pheochromocytoma
85. 131I-MIBG
86. 131I MIBG uptake in a non-secreting paraganglioma